Critics said today’s announcement is more evidence of the current administration’s willingness to undermine public trust in vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
International medical graduate physicians, or IMG physicians, make up about 25% of the practicing physicians in the United States, but they have made up 45% of COVID-related physician deaths, according to a JAMA Network Open research letter late last week.
The vaccine showed 100% protection against severe illness and 93% against variants of concern.
COVID-19 surges continue in South America, now the hardest-hit continent, and Africa is seeing a host of vaccine issues.
The FDA says 60 million doses of the one-shot Johnson & Johnson vaccine cannot be used because of possible contamination.
Preventive anticoagulation dosing for blood clots in the veins was tied to lower 60-day death rates.
A surveillance study of US children during the first wave of the pandemic found that multisystem inflammatory syndrome in children (MIS-C) was a rare complication associated with SARS-CoV-2 infection, but incidence was significantly higher in non-White racial and ethnic groups, US researchers reported yesterday in JAMA Network Open.
For every 20 percentage points of vaccinated people, positive COVID-19 tests in unvaccinated children halved.
The FDA has granted an extension on the shelf life of the Johnson & Johnson vaccine, to 4.5 months.
Elsewhere, European officials say only 30% of the population has received 1 vaccine dose.
High doses of intravenous immunoglobulin (IVIG) in conjunction with an anticoagulant were associated with resolved vaccine-induced immune thrombotic thrombocytopenia (VITT) in three patients, according to a report yesterday in the New England Journal of Medicine.
VITT occurs when antibodies attack protein factor 4 (PF4), leading to blood clumping and clots.
